These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10860476)

  • 1. [The current aspects of the prevention of hepatitis B at hemodialysis centers (a review of the literature)].
    Novozhenov VG; Sel'kova EP; Kozhokar' IuV; Zubkin ML
    Voen Med Zh; 2000 Apr; 321(4):56-61. PubMed ID: 10860476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B virus in a hemodialysis unit].
    Guma CL; Colombato LO; Alvarez E; Franco CO; Planes N
    Medicina (B Aires); 1985; 45(5):491-5. PubMed ID: 3842456
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of low dose intradermal recombinant hepatitis B vaccine with and without immunomodulation in end stage renal disease patients on maintenance hemodialysis.
    Sirsat RA; Shah BV; Nair S; Shetty D; Rodriguest C; Mehta A
    J Assoc Physicians India; 1995 Mar; 43(3):191-2. PubMed ID: 11256907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis prevention and its results--report of experiences in a dialysis department].
    Müller D
    Z Urol Nephrol; 1986 Dec; 79(12):729-32. PubMed ID: 3577440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
    Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
    Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B, prevalence and results of preventive measures in dialysis centers].
    Rosier JG; van der Hem GK
    Ned Tijdschr Geneeskd; 1986 Apr; 130(16):737-9. PubMed ID: 3713880
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B vaccination in patients with chronic renal failure].
    Jílková E; Jílek D; Bitterová Z; Král V; Trmal J; Richter J
    Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):135-9. PubMed ID: 9471302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 11. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vaccination against hepatitis B in a hemodialysis center].
    Jungers P
    Nephrologie; 1998; 19(1):37-8. PubMed ID: 9551451
    [No Abstract]   [Full Text] [Related]  

  • 13. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
    Kes P; Slavicek J; Janković N
    Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of hemodialysis recirculating apparatuses in the spread of HBsAg at Czechoslovak hemodialysis centers].
    Opatrný K; Vodák M; Zichová M; Farník J; Mladá L; Opatrný K; Köcher P
    Vnitr Lek; 1982 Aug; 28(8):802-5. PubMed ID: 7135867
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation.
    Rawer P; Willems WR; Breidenbach T; Guttmann W; Pabst W; Schütterle G
    Kidney Int Suppl; 1987 Oct; 22():149-52. PubMed ID: 3481000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis B vaccination in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the spread of hepatitis B in dialysis units.
    Bauer D
    Am J Nurs; 1980 Feb; 80(2):260-1. PubMed ID: 6898385
    [No Abstract]   [Full Text] [Related]  

  • 20. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.